Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,913.00    -25.00 (-1.29%)
Bid:
1,917.00
Ask:
1,918.00
Spread: 1.00 (0.052%)
Market Cap: £76.72b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

Emma Walmsley to step down as chief executive of GSK
29 Sep 2025

Emma Walmsley to step down as chief executive of GSK

(Sharecast News) - Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role.

LONDON MARKET CLOSE: Brighter US outlook fires up European stocks
26 Sep 2025

LONDON MARKET CLOSE: Brighter US outlook fires up European stocks

(Alliance News) - The FTSE 100 recorded strong gains on Friday as US data pointed to resilient consumer spending and relatively subdued inflation, kee...

Britain says pushing for better outcome on US pharma tariffs
26 Sep 2025

Britain says pushing for better outcome on US pharma tariffs

LONDON, Sept 26 (Reuters) - Britain on Friday said it was pressing the United States on pharmaceutical tariffs in hope of a beneficial outcome, afte...

Britain says pushing for better outcome on US pharma tariffs
26 Sep 2025

Britain says pushing for better outcome on US pharma tariffs

LONDON, Sept 26 (Reuters) - Britain on Friday said it was pressing the United States on pharmaceutical tariffs in hope of a beneficial outcome, afte...

Trump to impose tariffs of 100% on branded drug imports
26 Sep 2025

Trump to impose tariffs of 100% on branded drug imports

(Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US pres...

European pharma shares drop after Trump threatens more tariffs
26 Sep 2025

European pharma shares drop after Trump threatens more tariffs

LONDON, Sept 26 (Reuters) - Shares in Europe's biggest pharma companies fell in early trading on Friday, after U.S. President Donald Trump unveiled ...

FDA approves drug that Trump due to suggest as autism treatment
23 Sep 2025

FDA approves drug that Trump due to suggest as autism treatment

Sept 22 (Reuters) - The U.S. Food and Drug Administration announced approval of leucovorin, or folinic acid, that U.S. President Donald Trump was sl...